Literature DB >> 19560422

Cellular microRNA and P bodies modulate host-HIV-1 interactions.

Robin Nathans1, Chia-Ying Chu, Anna Kristina Serquina, Chih-Chung Lu, Hong Cao, Tariq M Rana.   

Abstract

MicroRNAs (miRNAs), approximately 22 nt noncoding RNAs, assemble into RNA-induced silencing complexes (RISCs) and localize to cytoplasmic substructures called P bodies. Dictated by base-pair complementarity between miRNA and a target mRNA, miRNAs specifically repress posttranscriptional expression of several mRNAs. Here we report that HIV-1 mRNA interacts with RISC proteins and that disrupting P body structures enhances viral production and infectivity. In HIV-1-infected human T lymphocytes, we identified a highly abundant miRNA, miR-29a, which specifically targets the HIV-1 3'UTR region. Inhibiting miR-29a enhanced HIV-1 viral production and infectivity, whereas expressing a miR-29 mimic suppressed viral replication. We also found that specific miR-29a-HIV-1 mRNA interactions enhance viral mRNA association with RISC and P body proteins. Thus we provide an example of a single host miRNA regulating HIV-1 production and infectivity. These studies highlight the significance of miRNAs and P bodies in modulating host cell interactions with HIV-1 and possibly other viruses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19560422      PMCID: PMC2763548          DOI: 10.1016/j.molcel.2009.06.003

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  30 in total

Review 1.  Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA.

Authors:  T M Rana; K T Jeang
Journal:  Arch Biochem Biophys       Date:  1999-05-15       Impact factor: 4.013

Review 2.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

3.  Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA.

Authors:  Catherine L Jopling; Minkyung Yi; Alissa M Lancaster; Stanley M Lemon; Peter Sarnow
Journal:  Science       Date:  2005-09-02       Impact factor: 47.728

4.  Inhibition of translational initiation by Let-7 MicroRNA in human cells.

Authors:  Ramesh S Pillai; Suvendra N Bhattacharyya; Caroline G Artus; Tabea Zoller; Nicolas Cougot; Eugenia Basyuk; Edouard Bertrand; Witold Filipowicz
Journal:  Science       Date:  2005-08-04       Impact factor: 47.728

Review 5.  Viruses and microRNAs.

Authors:  Bryan R Cullen
Journal:  Nat Genet       Date:  2006-06       Impact factor: 38.330

Review 6.  Control of translation and mRNA degradation by miRNAs and siRNAs.

Authors:  Marco Antonio Valencia-Sanchez; Jidong Liu; Gregory J Hannon; Roy Parker
Journal:  Genes Dev       Date:  2006-03-01       Impact factor: 11.361

7.  The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates.

Authors:  Kevin K Ariën; Awet Abraha; Miguel E Quiñones-Mateu; Luc Kestens; Guido Vanham; Eric J Arts
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

8.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Authors:  Ann M Sheehy; Nathan C Gaddis; Jonathan D Choi; Michael H Malim
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

9.  Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients.

Authors:  N J Deacon; A Tsykin; A Solomon; K Smith; M Ludford-Menting; D J Hooker; D A McPhee; A L Greenway; A Ellett; C Chatfield; V A Lawson; S Crowe; A Maerz; S Sonza; J Learmont; J S Sullivan; A Cunningham; D Dwyer; D Dowton; J Mills
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

10.  Changes in microRNA expression profiles in HIV-1-transfected human cells.

Authors:  Man Lung Yeung; Yamina Bennasser; Timothy G Myers; Guojian Jiang; Monsef Benkirane; Kuan-Teh Jeang
Journal:  Retrovirology       Date:  2005-12-28       Impact factor: 4.602

View more
  211 in total

1.  Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells.

Authors:  Jiang Li; Yifei Zhang; Ramalinga Kuruba; Xiang Gao; Chandrashekhar R Gandhi; Wen Xie; Song Li
Journal:  Mol Pharmacol       Date:  2011-04-21       Impact factor: 4.436

2.  EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency.

Authors:  Kasandra J Riley; Gabrielle S Rabinowitz; Therese A Yario; Joseph M Luna; Robert B Darnell; Joan A Steitz
Journal:  EMBO J       Date:  2012-03-30       Impact factor: 11.598

3.  Evidence for miRNA expression differences of HIV-1-positive, treatment-naive patients and elite suppressors: a re-analysis.

Authors:  Kenneth W Witwer; Janice E Clements
Journal:  Blood       Date:  2012-06-28       Impact factor: 22.113

Review 4.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

Review 5.  Function of a retrotransposon nucleocapsid protein.

Authors:  Suzanne B Sandmeyer; Kristina A Clemens
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

6.  HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs.

Authors:  J Robert Chang; Ruma Mukerjee; Asen Bagashev; Luis Del Valle; Tinatin Chabrashvili; Brian J Hawkins; Johnny J He; Bassel E Sawaya
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

Review 7.  HIV-1 transcription and latency: an update.

Authors:  Carine Van Lint; Sophie Bouchat; Alessandro Marcello
Journal:  Retrovirology       Date:  2013-06-26       Impact factor: 4.602

Review 8.  RNA viruses and microRNAs: challenging discoveries for the 21st century.

Authors:  Gokul Swaminathan; Julio Martin-Garcia; Sonia Navas-Martin
Journal:  Physiol Genomics       Date:  2013-09-17       Impact factor: 3.107

9.  MicroRNA binding to the HIV-1 Gag protein inhibits Gag assembly and virus production.

Authors:  Antony K Chen; Prabuddha Sengupta; Kayoko Waki; Schuyler B Van Engelenburg; Takahiro Ochiya; Sherimay D Ablan; Eric O Freed; Jennifer Lippincott-Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-17       Impact factor: 11.205

10.  Replication of many human viruses is refractory to inhibition by endogenous cellular microRNAs.

Authors:  Hal P Bogerd; Rebecca L Skalsky; Edward M Kennedy; Yuki Furuse; Adam W Whisnant; Omar Flores; Kimberly L W Schultz; Nicole Putnam; Nicholas J Barrows; Barbara Sherry; Frank Scholle; Mariano A Garcia-Blanco; Diane E Griffin; Bryan R Cullen
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.